Psoriatic arthritis: open trials in United Kingdom

11 open trials have a site in United Kingdom. Registry data; only the trial team decides who can take part.

NCT03773965
A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis
Trial Treatment · Phase 3 · Eli Lilly and Company
Bristol Royal Hospital for Children, Bristol · Alder Hey Children's Hospital, Liverpool · Great Ormond Street Hospital For Children NHS Foundation Trust, London · Oxford University Hospitals - Nuffield Orthopaedic Centre, Oxford · Sheffield Children's Hospital, Sheffield
Registry updated 2026-11-04
NCT06663332
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
Sheffield Children's Hospital, Sheffield · Royal Stoke University Hospital, Stoke-on-Trent · Haywood Hospital, Stoke-on-Trent
Registry updated 2026-11-03
NCT07166315
Treatment Effectiveness in People With axSpA or PsA Starting Treatment With Bimekizumab, Risankizumab, Guselkumab, Upadacitinib, or a TNF Inhibitor
Research · Adelphi Real World
Royal National Hospital for Rheumatic Diseases, Bath
Registry updated 2026-10-27
NCT06668181
An Open-label Study to Evaluate the Pharmacokinetics and Safety of Bimekizumab in Pediatric Study Participants With Active Juvenile Idiopathic Arthritis Subtypes Enthesitis-related Arthritis (Including Juvenile-onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis
Trial Treatment · Phase 3 · UCB Biopharma SRL
Ja0005 40786, Bristol · Ja0005 40783, Manchester · Ja0005 40785, Nottingham · Ja0005 40784, Stoke-on-Trent
Registry updated 2026-10-23
NCT04804553
Apremilast Pediatric Study in Children With Active Juvenile Psoriatic Arthritis
Trial Treatment · Phase 3 · Amgen
Birmingham Childrens Hospital, Birmingham · Alder Hey Childrens Hospital, Liverpool · Nottingham Childrens Hospital, Nottingham · John Radcliffe Hospital, Oxford
Registry updated 2026-10-20
NCT06100744
A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
Trial Treatment · Phase 3 · AbbVie
University Hospitals Bristol and Weston NHS Foundation Trust /ID# 258847, Bristol · Alder Hey Children's NHS Foundation Trust /ID# 262770, Liverpool · Sheffield Children's Hospital NHS Foundation Trust /ID# 258848, Sheffield
Registry updated 2026-09-01
NCT07417995
A Study of Clinical and Immune Responses to Sequential Biologic Therapies in Psoriatic Arthritis
Research · Royal United Hospitals Bath NHS Foundation Trust
Royal United Hospitals Bath NHS Foundation Trust, Bath
Registry updated 2026-05-13
NCT07443956
Combination of Biologic and Anti-obesity Therapies in Psoriatic Arthritis
Trial Treatment · NHS Greater Glasgow and Clyde
University Hospitals Birmingham NHS Foundation Trust, Birmingham · University Hospitals Coventry and Warwickshire NHS Trust, Coventry · NHS Greater Glasgow and Clyde, Glasgow · The Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne
Registry updated 2026-05-04
NCT07403890
Rewiring the Brain-Immune Axis for Chronic Pain Using Transcranial Magnetic Stimulation in Psoriatic Arthritis
Trial Treatment · NHS Greater Glasgow and Clyde
Queen Elizabeth University Hospital, Glasgow
Registry updated 2026-02-11
NCT06786936
Evaluating the Role of IL-17 as an Orchestrator of Peripheral-central Cross Talk in Depressive Symptoms
Research · NHS Greater Glasgow and Clyde
Queen Elizabeth University Hospital, Glasgow
Registry updated 2025-06-19
NCT05858528
HIPPOCRATES Prospective Observational Study
Research · University of Oxford
Oxford University Hospital NHS Foundation Trust, Oxford
Registry updated 2025-04-02

All Psoriatic arthritis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error